TACE Plus Drug Combination Effective in Liver Cancer
March 7, 2025, by Carmen Phillips Some people with liver cancer are treated with a procedure called transarterial chemoembolization, or...
cancer
The timing breakthrough in liver cancer treatment
In a significant step forward for liver cancer treatment, researchers have found that a gap of at least 50 days...
Namodenoson Shows Protective Effects Beyond Liver Cancer in Can-Fite’s Pivotal Study
Can-Fite BioPharma (NYSE: CANF) announced the publication of an innovative study in the European Society of Medicine...
Namodenoson in Liver Cancer Treatment Alongside with Cardiac, Liver, and Neurological Benefits
Can-Fite BioPharma Ltd. Unlike chemotherapy with its known toxicity towards normal body systems, Namodenoson provides protective effects Ramat Gan, Israel,...
Projected epidemiological trends and burden of liver cancer by 2040 based on GBD, CI5plus, and WHO data
Liver cancer incidence and mortality rates estimates in 2020 and comparison by HDIAccording to the GLOBOCAN estimates, there were 905,000...
Liver Cancer Therapeutics Market to Hit USD 15.69 Billion
Pune, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Liver Cancer Therapeutics Market Size & Growth Analysis: “According to SNS Insider, The global...
